
Rei Tsang Shiao
Examiner (ID: 13461, Phone: (571)272-0707 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9436026
[patent_doc_number] => 20140113933
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2014-04-24
[patent_title] => 'Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide'
[patent_app_type] => utility
[patent_app_number] => 13/858750
[patent_app_country] => US
[patent_app_date] => 2013-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13907
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/858750 | Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide | Apr 7, 2013 | Abandoned |
Array
(
[id] => 9436026
[patent_doc_number] => 20140113933
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2014-04-24
[patent_title] => 'Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide'
[patent_app_type] => utility
[patent_app_number] => 13/858750
[patent_app_country] => US
[patent_app_date] => 2013-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13907
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/858750 | Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide | Apr 7, 2013 | Abandoned |
Array
(
[id] => 9786316
[patent_doc_number] => 20140303137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/857253
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14059
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857253
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/857253 | AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS | Apr 4, 2013 | Abandoned |
Array
(
[id] => 9710926
[patent_doc_number] => 08835494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Derivatives of 1-(2-halo-biphenyl-4-yl)-Alkanecarboxylic for the treatment of neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 13/855915
[patent_app_country] => US
[patent_app_date] => 2013-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8344
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855915
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/855915 | Derivatives of 1-(2-halo-biphenyl-4-yl)-Alkanecarboxylic for the treatment of neurodegenerative diseases | Apr 2, 2013 | Issued |
Array
(
[id] => 10202629
[patent_doc_number] => 20150087617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'INDOLE, INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/390171
[patent_app_country] => US
[patent_app_date] => 2013-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 67874
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390171
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390171 | Indole, indoline derivatives, compositions comprising them and uses thereof | Apr 1, 2013 | Issued |
Array
(
[id] => 10202719
[patent_doc_number] => 20150087707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => '4-OXO-2-PENTENOIC ACID AND CARDIOVASCULAR HEALTH'
[patent_app_type] => utility
[patent_app_number] => 14/389451
[patent_app_country] => US
[patent_app_date] => 2013-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6954
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389451
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389451 | 4-oxo-2-pentenoic acid and cardiovascular health | Mar 24, 2013 | Issued |
Array
(
[id] => 10844613
[patent_doc_number] => 08871785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Antiviral phosphonate analogs'
[patent_app_type] => utility
[patent_app_number] => 13/848593
[patent_app_country] => US
[patent_app_date] => 2013-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 237027
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848593
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/848593 | Antiviral phosphonate analogs | Mar 20, 2013 | Issued |
Array
(
[id] => 11318145
[patent_doc_number] => 09516877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => 'Antimicrobial alcohol foam compositions and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 14/387989
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8754
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387989
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/387989 | Antimicrobial alcohol foam compositions and methods of preparation | Mar 14, 2013 | Issued |
Array
(
[id] => 8964089
[patent_doc_number] => 20130203691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'STABLE INSECTICIDE COMPOSITIONS AND METHODS FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/833069
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18067
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13833069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/833069 | Stable insecticide compositions and methods for producing same | Mar 14, 2013 | Issued |
Array
(
[id] => 11479375
[patent_doc_number] => 09585896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/390127
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11994
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390127
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390127 | Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 11218718
[patent_doc_number] => 09447047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Inhibitors of protein phosphatase-1 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/421757
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13484
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421757 | Inhibitors of protein phosphatase-1 and uses thereof | Mar 13, 2013 | Issued |
Array
(
[id] => 9408991
[patent_doc_number] => 20140100243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE AMIDES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/801376
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22010
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801376
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801376 | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use | Mar 12, 2013 | Issued |
Array
(
[id] => 8951249
[patent_doc_number] => 20130197030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Substituted 1,3-Dioxanes and There Uses'
[patent_app_type] => utility
[patent_app_number] => 13/790007
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18498
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13790007
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/790007 | Substituted 1,3-Dioxanes and There Uses | Mar 7, 2013 | Abandoned |
Array
(
[id] => 9813104
[patent_doc_number] => 20150025048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'METHODS FOR ENHANCING, IMPROVING, OR INCREASING FERTILITY OR REPRODUCTIVE FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 14/383269
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21807
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383269
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/383269 | Methods for enhancing, improving, or increasing fertility or reproductive function | Mar 6, 2013 | Issued |
Array
(
[id] => 9902167
[patent_doc_number] => 20150057366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'SYNTHESIS OF ELEMICIN AND TOPICAL ANALGESIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/383355
[patent_app_country] => US
[patent_app_date] => 2013-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9734
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383355
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/383355 | SYNTHESIS OF ELEMICIN AND TOPICAL ANALGESIC COMPOSITIONS | Mar 4, 2013 | Abandoned |
Array
(
[id] => 11794107
[patent_doc_number] => 09403857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Compositions and methods for the treatment of metabolic syndrome'
[patent_app_type] => utility
[patent_app_number] => 14/399198
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9447
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399198
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399198 | Compositions and methods for the treatment of metabolic syndrome | Feb 27, 2013 | Issued |
Array
(
[id] => 8928584
[patent_doc_number] => 20130184344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'LEVODOPA PRODRUG MESYLATE HYDRATE'
[patent_app_type] => utility
[patent_app_number] => 13/769625
[patent_app_country] => US
[patent_app_date] => 2013-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18928
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13769625
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/769625 | Levodopa prodrug mesylate hydrate | Feb 17, 2013 | Issued |
Array
(
[id] => 9551782
[patent_doc_number] => 08758828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Process for preparing cyclic esters comprising unsaturated functional groups and polyesters prepared from same'
[patent_app_type] => utility
[patent_app_number] => 13/768742
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8693
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768742
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768742 | Process for preparing cyclic esters comprising unsaturated functional groups and polyesters prepared from same | Feb 14, 2013 | Issued |
Array
(
[id] => 10128119
[patent_doc_number] => 09161940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => 'Selective estrogen receptor modulators with short half-lives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/378573
[patent_app_country] => US
[patent_app_date] => 2013-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5316
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378573
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/378573 | Selective estrogen receptor modulators with short half-lives and uses thereof | Feb 13, 2013 | Issued |
Array
(
[id] => 8884897
[patent_doc_number] => 20130158081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/764807
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12657
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13764807
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/764807 | Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid | Feb 11, 2013 | Issued |